Author(s): Syed Safiullah Ghori, Mohammed Abdul Quddus, Hafsa Khalid

Email(s): safiullahghori@gmail.com

DOI: 10.5958/0974-360X.2017.00308.0   

Address: Syed Safiullah Ghori, Mohammed Abdul Quddus, Hafsa Khalid
Department of Hospital and Clinical Pharmacy, Anwar-ul-Uloom College of Pharmacy, New Mallepally, Hyderabad 500016, Telangana, India
*Corresponding Author

Published In:   Volume - 10,      Issue - 6,     Year - 2017


ABSTRACT:
Patients on anti-tuberculosis treatment develop acute kidney injury (AKI) especially in an aging population. This study aimed to calculate the incidence of AKI due to anti-TB drugs and to analyse the outcomes and predictors of renal recovery. Patients on anti-TB treatment during the year 2015 and 2016 were identified and their medical records were reviewed. Acute kidney injury was identified according to the criteria established by the AKI Network, while renal recovery was calculated as a return of serum creatinine to baseline. Predictors of renal recovery were analysed by Cox regression analysis. 61 patients of the age 68 years on anti-TB treatment had AKI with male predominance. 43 (71%) developed AKI within two months of anti-TB treatment, including 3 (5%) with a prior history of rifampin exposure. 30 (26%) had co-morbid chronic kidney disease or end-stage renal disease. The median time of renal recovery was 39.6 days. Factors predicting renal recovery were, presence of fever, rash, and gastro-intestinal disturbance at the onset of AKI. 51 of the 60 patients who recovered from AKI had successful re-introduction or continuation of rifampin. The present study suggests that acute kidney injury is caused by anti-tuberculosis drugs mainly in geriatrics. Some of the patients with acute kidney injury recovered and some of them had permanent renal impairment. Patients with predictable factors of fever, rash, and gastrointestinal disturbance at the onset of acute kidney injury had better renal recovery. Further research efforts should be directed towards better findings related to association of anti-tuberculosis drugs with acute kidney injury and increasing systematic strategies for prevention.


Cite this article:
Syed Safiullah Ghori, Mohammed Abdul Quddus, Hafsa Khalid. A Clinical Study of Acute Kidney Injury on using Antituberculosis Drugs in Geriatrics. Research J. Pharm. and Tech. 2017; 10(6): 1746-1750. doi: 10.5958/0974-360X.2017.00308.0


Recomonded Articles:

Author(s): Abhirup Dey, Mangala Lakshmi Ragavan, Sanjeeb Kumar Mandal, Nilanjana Das

DOI: 10.5958/0974-360X.2017.00136.6         Access: Open Access Read More

Author(s): M. Sumithra, Avantika Prabhabanik

DOI: 10.5958/0974-360X.2017.00036.1         Access: Open Access Read More

Author(s): Mohd Yousuf Ali, Md Shamim Qureshi, Md Hamed, Byasabhusan Das and K Purushotham Rao

DOI: Not Available         Access: Open Access Read More

Author(s): Yarnykh T.G., Azarenko Iu. M., Buryak M.V., Bubilieva L. A.

DOI: 10.5958/0974-360X.2016.00115.3         Access: Open Access Read More

Author(s): Sarumathy S., CH Haripriya, Muddala Vara Prasanna Rao, Gayathri K., CH Bala Sudhakar, Divya M., Shanmugasundaram P.

DOI: 10.5958/0974-360X.2015.00272.3         Access: Open Access Read More

Author(s): Tapan Kumar Giri, Saumya Mishra, Dulal Krishna Tripathi

DOI: Not Available         Access: Open Access Read More

Author(s): A. Shreya Svitlana

DOI: 10.5958/0974-360X.2016.00243.2         Access: Open Access Read More

Author(s): J. Satyanarayana, A. Pavan Kumar, V. Sai Kishore, T.E. Gopala Krishna Murthy

DOI: Not Available         Access: Open Access Read More

Author(s): Sahil Choudhari, Vishnu Priya .V, R. Gayathri

DOI: 10.5958/0974-360X.2016.00362.0         Access: Open Access Read More

Author(s): Mahadeva Rao U.S., Suganya M. Utharkar, C. Shanmuga Sundaram

DOI: 10.5958/0974-360X.2015.00307.8         Access: Open Access Read More

Author(s): V. Swathi, G. Velrajan, Balasubramaniam

DOI: Not Available         Access: Open Access Read More

Author(s): Alai M.S., Shinkar D.M., Saudagar R.B.

DOI: 10.5958/0974-360X.2017.00646.1         Access: Open Access Read More

Author(s): Suman Katteboina and VSR Chandrasekhar P

DOI: Not Available         Access: Open Access Read More

Author(s): K.V. Swathi

DOI: 10.5958/0974-360X.2016.00239.0         Access: Open Access Read More

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags